Research Report on the Digital Maturity Gap
While 94% of pharma manufacturers have adopted AI tools, most lack the foundational system integration required to unlock their true potential. This exclusive industry research reveals why nearly half of life sciences organizations cite integration issues and data security as the biggest barriers preventing AI deployment, and what separates leaders from laggards in achieving fruitful AI deployments.
Discover how the pharmaceutical industry's digital maturity has evolved, where organizations stand on the path from manual to intelligent operations, and the critical infrastructure investments needed to accelerate AI integration. Learn why 59% recognize that connected systems are the essential prerequisite for AI success, yet no organizations report having achieved fully intelligent operational states where AI systematically drives manufacturing and quality decisions.
Digital maturity is about much more than technology adoption. It's about integration depth. Pharma manufacturers have eliminated purely manual operations, dropping from 9% to just 1% in three years. Yet connected operations represent only 48% of the industry, and there are still only 1% of organizations with truly intelligent AI-driven processes. The research reveals that without foundational system integration, even sophisticated AI tools cannot deliver predictive quality insights, streamline regulatory compliance, or eliminate the costly rework affecting 96% of organizations. Integration isn't a future goal—it's the prerequisite for competitive advantage in modern pharma manufacturing.
Get exclusive insights on accelerating your path to AI-driven manufacturing.
Access the Report NowYes! The report identifies specific strategies that forward-thinking pharma companies should be implementing to achieve full AI readiness. Download the report to benchmark your organization against industry leaders.
The report ranks regulatory concerns among top barriers to AI implementation accordingly. Get the report to learn how leading pharma companies are addressing these unique challenges.
Yes! Our research reveals a realistic timeline to achieve full adoption over the next couple of years that may surprise pharma executives. Download the report to align your AI roadmap with industry expectations.
Yes! Our research report ranks the foundational elements required before meaningful AI implementation. See if your organization has established the necessary prerequisites.
MasterControl's fully integrated AI-powered solutions address the critical gap between AI ambition and execution. By providing a unified, connected foundation for quality and manufacturing operations, the MasterControl platform enables pharma manufacturers to deploy AI safely, responsibly, and at scale, accelerating the industry's typical 3-5 year timeline.
Start with integrated quality and manufacturing systems from day one, eliminating the technical debt of disconnected point solutions that plague 94% of organizations struggling with siloed production systems
MasterControl lets you deploy AI capabilities on clean, structured data to predict quality issues before they occur, addressing the 98% of manufacturers currently lacking proactive risk indicators and early warning systems.
Achieve AI deployment with our ISO 42001-certified AI management systems, addressing the 25% of organizations citing data privacy and security as their primary barrier to AI integration.
Deploy according to your readiness with flexible, staged implementation that supports the 55% reporting partial deployment, building incrementally toward intelligent operations without disrupting current processes.
Explore the digital divide in CDMO manufacturing from surveyed research